myTomorrows

myTomorrows is a healthcare technology company founded in 2012 that builds software to connect patients and their physicians with clinical trials and expanded access programs worldwide. Its central technical product, the myTomorrows platform, applies AI-powered matching to identify suitable trials for patients who have exhausted standard treatment options, searching across trial and access programmes on a global basis. The company's work sits at the intersection of clinical trials, expanded access and compassionate use, operating within healthcare and pharmaceutical markets.

The platform is paired with a multilingual Patient Navigator team that provides personalised support to patients throughout the treatment-access journey, combining automated matching with human guidance. The company works collaboratively with BioPharma companies, healthcare professionals and patient advocacy groups, and employs a mix of healthcare and technology professionals.

myTomorrows was founded after the company's founder, Ronald Brus, lost his father to lung cancer and encountered how slow and complicated accessing treatments in development can be. The stated aim is to make tomorrow's treatments available today for those who need them most. The company describes its reach as worldwide; team size and funding figures are not stated.